Fulcrum Therapeutics (FULC) Q3 2025 Earnings

29JulConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.4
-0.36
-0.32
-0.28

Details

Expected EPS
-0.29
Actual EPS
-0.28
Surprise EPS
0.01
Surprise Percent
+3.45%

Description

Fulcrum Therapeutics (FULC) has reported earnings of -0.28 per share for Q3 2025.

0 Comments

Share your thoughts